Hannes Becker
LightNews LightNews
banner
hannes-becker1996.bsky.social
Hannes Becker
@hannes-becker1996.bsky.social
47 followers 79 following 6 posts
🧑‍🔬🧫🧑‍⚕️Clinician Scientist @NeuroOncoTue.bsky.social
🧠🏥Neurosurgical Resident @University Hospital Tuebingen
Posts Replies Media Videos
hannes-becker1996.bsky.social
Very happy to had the opportunity to present our data at the DGN in Berlin.
@ghtabatabai.bsky.social
@hih-tuebingen.bsky.social
@dgn-ev.bsky.social
November 14, 2025 at 6:34 PM
Reposted by Hannes Becker
neurooncotue.bsky.social
We had a wonderful #eano2025 in Prague, with multiple talks and poster presentations and fruitful discussions!
Looking forward to Rome!
@eanoassociation.bsky.social
@ghtabatabai.bsky.social
@hannes-becker1996.bsky.social
@nihalolcaydogan.bsky.social
@hih-tuebingen.bsky.social
October 21, 2025 at 8:22 AM
Reposted by Hannes Becker
neurooncotue.bsky.social
Now Surender Surender on stage, presenting our data on CDK4/6 inhibition in experimental glioma!
@eanoassociation.bsky.social
@ghtabatabai.bsky.social
@hih-tuebingen.bsky.social
October 18, 2025 at 10:48 AM
Reposted by Hannes Becker
neurooncotue.bsky.social
Great talk by @ghtabatabai.bsky.social about time management in academia
@eanoassociation.bsky.social
October 18, 2025 at 8:03 AM
hannes-becker1996.bsky.social
Glad to have the opportunity to present our data!
@eanoassociation.bsky.social
ghtabatabai.bsky.social Ghazaleh Tabatabai @ghtabatabai.bsky.social · Oct 17
And now it‘s Hannes Becker on stage, presenting our data at EANO2025 👍🏼🙌 @neurooncotue.bsky.social
October 17, 2025 at 5:02 PM
Reposted by Hannes Becker
neurooncotue.bsky.social
Nice opportunity to present our data on regorafenib in combination with navitoclax at @eanoassociation.bsky.social
@hannes-becker1996.bsky.social
@ghtabatabai.bsky.social
ghtabatabai.bsky.social Ghazaleh Tabatabai @ghtabatabai.bsky.social · Oct 17
And now it‘s Hannes Becker on stage, presenting our data at EANO2025 👍🏼🙌 @neurooncotue.bsky.social
October 17, 2025 at 5:01 PM
Reposted by Hannes Becker
neurooncotue.bsky.social
Great comprehensive talk by @ghtabatabai.bsky.social to give insights into CRISPR screen.
More to come!
@eanoassociation.bsky.social
October 17, 2025 at 7:38 AM
Reposted by Hannes Becker
neurooncotue.bsky.social
Extremely happy that we could have contributed!
michael-platten.bsky.social Michael Platten, MD @michael-platten.bsky.social · Jul 29
Excited to announce that we have completed accrual of the INTERCEPT-H3 trial (NCT04808245). This phase 1 first-in-human trial explores safety and immunogenicity of a long peptide vaccine targeting the clonal driver mutation H3K27M in adult patients with newly diagnosed diffuse midline gliomas 1/
September 29, 2025 at 7:26 AM
Reposted by Hannes Becker
neurooncotue.bsky.social
Innovative trial design, thank you for the opportunity for being part of it!
September 29, 2025 at 7:30 AM
Reposted by Hannes Becker
eanoassociation.bsky.social
🧠 Recently published in Neuro-Oncology: EANS–EANO Guidelines on the Extent of Resection in Gliomas. We’re proud to share the outcome of collaborative effort by the joint task force of EANS and EANO, providing evidence-based recommendations for clinical practice.
🔗 academic.oup.com/neuro-oncolo...
September 24, 2025 at 12:28 PM
Reposted by Hannes Becker
eanoassociation.bsky.social
🧠 The phase 1/2 N2M2 umbrella trial lead by former EANO president @wickwolfgang.bsky.social has just been published in Nature Medicine
🔗 www.nature.com/articles/s41...

#NeuroOncology #EANOessentials #BrainTumors #CancerResearch
Molecularly matched targeted therapies plus radiotherapy in glioblastoma: the phase 1/2a N2M2 umbrella trial - Nature Medicine
In a phase 1/2a umbrella trial in patients with glioblastoma matching targeted therapies according to tumor molecular profiling, temsirolimus plus radiotherapy improved PFS compared to standard of car...
www.nature.com
September 9, 2025 at 8:14 PM
hannes-becker1996.bsky.social
Glad to present our data at this years #DGNC2025
neurooncotue.bsky.social Neurooncology Tuebingen @neurooncotue.bsky.social · Jun 3
Thank you for having the opportunity to present our data at this year DGNC in Hanover.
#DGNC2025
June 3, 2025 at 7:39 AM
Reposted by Hannes Becker
neurooncotue.bsky.social
Thank you for having the opportunity to present our data at this year DGNC in Hanover.
#DGNC2025
June 3, 2025 at 7:38 AM
Reposted by Hannes Becker
ghtabatabai.bsky.social
Almost 25 year old T-shirt, reminds me of great experience at MGH/HMS 2000/2001, @harvard.edu - hard to see this institution under pressure now, and impressed by the integrity and resilience of Harvard leadership (more on LinkedIn) 🙌 #Harvard #AcademicFreedom #ScienceForDemocracy #ScienceMatters
April 20, 2025 at 7:19 PM
Reposted by Hannes Becker
luisaneubauer.bsky.social
Hoffnung fällt nicht vom Himmel.
Hoffnung ist harte Arbeit.
Heute, morgen, übermorgen.
Wir sind da. Und wir sind viele.
February 23, 2025 at 9:14 PM
Reposted by Hannes Becker
hih-tuebingen.bsky.social
Thank you for your engagement Ghazaleh Tabatabai 🙏 #aufstehenfuerdemokratie
February 21, 2025 at 8:07 AM
hannes-becker1996.bsky.social
#aufstehenfuerdemokratie
February 20, 2025 at 10:41 PM
Reposted by Hannes Becker
ghtabatabai.bsky.social
Tübingen 12 Feb 2025
Geschwister Scholl Platz
Democracy needs facts
Science needs Democracy.
#aufstehenfuerdemokratie
February 12, 2025 at 6:58 PM
Reposted by Hannes Becker
winklerlab.bsky.social
📢 Es ist 5 vor 12❗

"Aufstehen für Demokratie" setzt sich für faktenbasierte politische Entscheidungen und Demokratie ein:
www.aufstehenfuerdemokratie.de
www.openpetition.de/!ychtb

📅 Sei dabei am 12.02 um 11:55 Uhr an Hochschulen und Forschungseinrichtungen

🔬 Wissenschaft braucht Demokratie 🤝
February 7, 2025 at 4:53 PM
hannes-becker1996.bsky.social
Great to see this finally out😍
Glad that I could contribute to this exciting Story!

@hih-tuebingen.bsky.social
@unituebingen.bsky.social
January 16, 2025 at 2:45 PM
hannes-becker1996.bsky.social
Happy that I could contribute to this fantastic work!
Check it out😉
January 7, 2025 at 9:09 PM
Reposted by Hannes Becker
icomeningioma.bsky.social
@ghtabatabai is a neurologist and a physician scientist at the University of Tübingen and the Managing Director Neurology at the University Hospital Tübingen.

Her research includes target discovery & validation, molecular mechanisms of treatment resistance, & novel delivery routes to brain tumors.
Member Spotlight: Dr. Ghazaleh Tabatabai
December 16, 2024 at 11:46 AM